» Współczesne zagrożenia zakażeniami wirusowymi

*Tadeusz Płusa

Współczesne zagrożenia zakażeniami wirusowymi

Actual threats of viral infections

Wojskowy Instytut Medyczny, Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii CSK MON w Warszawie,
Kierownik Instytutu: prof. dr hab. med. Tadeusz Płusa

Summary

Key words:

Piśmiennictwo

1. Ingesby T.V., Henderson D.A., Bartlett J.G. i wsp.: Anthrax as a biological weapon. Medical and public health management. JAMA, 1999, 18, 1735-1744. 2. Chomiczewski K.: Wspó-czesne poglądy na zagrożenie bronią biologiczną. Lek. Wojsk., 2002,78/1,5-9. 3. Franz D.R., Jahring P.B., Friedlander A.M. i wsp.: Clinical recognition and management of patients exposed to biological warfare agents. JAMA, 1997, 278/5, 399-411. 4. Gall W., Grzybowski J.: Wybrane zagadnienia dochodzenia epidemiologicznego w przypadkach militarnego lub terrorystycznego ataku biologicznego. - w: Chomiczewski K., Grzybowski J., Gall W. (red.): Epidemiologia dzia-ań wojennych i katastrof. ß. Medica Press, Bia-a Podlaska, 2001,66-82. 5. Holloway H.C., Norwood A.E., Fullerton C.S. i wsp.: The treat of biological weapons. Prophylaxis and mitigation of psychological and social consequences. JAMA, 1997, 278/5, 425-7. 6. Voelker R.: Surviving Ebola. JAMA, 1999,281,18. 7. Zaiki S.R.: A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread and surveillance of Ebola hemorrhagic fever. J. Infect. Dis., 1999, 179/suppl.1, S36-47. 8. P-usa T., Jahnz-Różyk K.: Broń biologiczna. Medpress, Warszawa,2002. 9. Kallio-Kokko H., Laakkonen J., Rizzoli A. et al.: Hantavirus and arenavirus antibody prevalence in rodents and humans in Trentino, Northern Italy. Epidemiol. Infect., 2005,1-7, 21-5. 10. Tkachenko E.A., Okulova N.M., Iunicheva I.V. et al.: The epizootological and virological characteristics of a natural hantavirus infection focus in the subtropic zone of the Krasnodarsk Territory. Vopr. Virusol., 2005, 50/3,14-9. 11. Kanerva M., Mustonen J., Vaheri A.: Pathogenesis of Puumala and other Hantavirus infections. Rev. Med. Virol., 1998, 8, 67-86. 12. Lednicky J.A.: Hantaviruses. A short review. Arch. Pathol. Lab. Med., 2003, 127, 30- 35. 13. McCaughey C., Hart C.A.: Hantaviruses. J. Med. Microbiol., 2000, 49, 587-599. 14. Douglass R.J., Calisher C.H., Bradley K.C.: State-by-state incidences of hantavirus pulmonary syndrome in the United States, 1993-2004. Vector Borne Zoonotic Dis., 2005, 5/2,189-92. 15. Qiao G., PangS.S., Zhang H.L. et al.: Analysis of part of M gene and genotyping for M segment of hantavirus detected from HFRS patients´ sera in Qingdao region during 2000-2003. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi,2005,19/1,22-4. 16. Tai P.W., Chen L.C., Huang C.H.: Hanta hemorrhagic fever with renal syndrome: a case report and review. J. Microbiol. Immunol. Infect., 2005, 38/3,221-3. 17. Sandmann S., Meisel H., Razanskiene A. et al.: Detection of human hantavirus infections in Lithuania. Infection, 2005,33/2,66-72. 18. Severson W., Xu X., Kuhn M. et al.: Essential amino acids of the hantaan virus N protein in its interaction with RNA. J. Virol., 2005,79/15,1032-9. 19. Strady C., Jaussaud R., Remy G. et al.: Hantavirus infections. Presse Med., 2005, 34/5,391-9. 20. Mailles A., Vaillant V., Haeghebaert S. et al.: Increase of Hantavirus infections in France, 2003. Med. Mal. Infect., 2005, 35/2,68-72. 21. Khan A.S., Kitsutani P.T., Corneli A.L.: Hantavirus pulmonary syndrome in the Americas: the early years. Semin. Respir. Crit. Care Med., 2000,21/4,313-22. 22. Cvetko L., Markotic A., Plyusnina A. et al.: Puumala virus in Croatia in the 2002 HFRS outbreak. J. Med. Virol., 2005, 77/2,290-4. 23. Centers for Disease Control and Prevention: Update: outbreak of severe acute respiratory syndrome - worldwide 2003. MMWR Morb. Mortal. Wkly. Rep. 52: 241-248. 24. de Jong M.D., Bach V.C., Phan T.Q et al.: Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med., 2005, 353:686-691. 25. Marra M.A., Jones S.J.M., Astell C.R. et al.: The genome sequence of the SARS-associated coronavirus. Science 2003; 300: 1399-1404. 26. Ruan Y-J, Wel C.L., Ee L.A. et al.: Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003; 361: 1779-1785. 27. World Health Organisation: Acute respiratory syndrome in China - update 3: disease outbreak reported. Geneva:, February 2003. (Accessed April 22, 2003, at http://www.who.int/csr/don/2003_2_20/en). 28. Peiris J.S.M., Chu C.M., Cheng V.C.C. et al.: Clinical progression and viral load in a community outbreak of coronaviruse-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767-1772. 29. World Health Organisation. Case definition for surveillance of severe acute respiratory syndrome (SARS). Revised 2003 May 1. Available: www.who.int/csr/sars/casedefinition/en. 30. Liu C-L, Lu Y-T., Peng M-J. et al.: Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest 2004; 126: 509-517. 31. Wong S.Y., Yuen K-Y.: Avian influenza virus infections in human. Chest, 2006, 129/1,156-168. 32. Poutanen S.M., Low D.E., Henry B.: Idnetification of severe acute respiratory syndrome in Canada. NEJM 2003; 348: 1995-2005. 33. Perez D., Sorrell E.M., Donis R.O.: Avian influenza. An omnipresent pandemic treat. Ped. Infect. Dis. J., 2005, 24/11,S208-S216. 34. Slemons R.D., Easterday B.C.: Virus replication in the digestive tract of ducks exposed by aerosol to type A influenza. Avian Dis., 1978, 22: 367-377. 35. The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med., 2005, 353:1374-1385. 36. Chotpitayasunondh T., Ungchusak K., Ilanshaoworakul W. et al.: Human disease from influenza A (H5N1), Thailand, 2004. Emerg. Infect.Dis., 2005, 11:201-209. 37. Tran T.I.I., Nguyen T.L., Nguyen T.D. et al.: Avian influenza A (H5N1) in 10 patients in Vietnam. N. Engl. J. Med., 2004,350: 1179-1188. 38. Rota P.A., Oberste M.S., Monroe S.S. et al.: Characterization of a novel coronavirus associated with the severe acute respiratory syndrome. Science 2003; 300: 1394-1399. 39. Spackman E., Senne D.A., Myers T.J. et al.: Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol., 2002, 40: 3256-3260. 40. McKimm-Breschkin J., Trivedi T., Hampson A. et al.: Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother., 2003, 47: 2264-2272. 41. Le Q.M., Kiso M., Someya K. et al.: Avian flu: isolation of drug-resistent H5N1 virus. Nature, 2005, 437: 1108. 42. Liem N.T., Lim W.: World Health Organization International Avian Influenza Investigation Team, Vietnam. Lack of H5N1 avian influenza transmission to hospital employers, Hanoi, 2004. Emerg. Infect. Dis., 2005, 11:210-215. 43. Goroux J.N.: Generalites sur l´arme biologique. Med.Arm., 2001, 29/4, 381-93. 44. Mulic R., Ropac D.: Epidemiologic characteristics and military implications of hemorrhagic fever with renal syndrome in Croatia. Croat. Med. J., 2002, 43, 581-6.

otrzymano/received: 2009-03-10
zaakceptowano/accepted: 2009-04-02

Adres/address:
* Tadeusz Płusa
Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii CSK MON, WIM
ul. Szaserów 128, 00-909 Warszawa
tel.: (0-22) 681-65-81/88
e-mail: tplusa@wim.mil.pl

Pełna wersja artykułu Współczesne zagrożenia zakażeniami wirusowymi dostępna w Czytelni Medycznej Borgis.

Copyright © Wydawnictwo Medyczne Borgis Sp. z o.o. 2007-2013
Chcesz być na bieżąco? Polub nas na Facebooku: strona Wydawnictwa na Facebooku